University of New Mexico (UNM) / Universidad de Nuevo México

Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study (2018) Dixon-Suen SC, Nagle CM, Thrift AP, Pharoah PDP, Ewing A, Pearce CL, Zheng W, et al. Journal article Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study (2018) Rambau PF, Vierkant RA, Intermaggio MP, Kelemen LE, Goodman MT, Herpel E, Pharoah PD, et al. Journal article rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology (2018) Kelemen LE, Earp M, Fridley BL, Chenevix-Trench G, Fasching P, Beckmann M, Ekici AB, et al. Journal article Cardioembolic Stroke Risk and Recovery After Anticoagulation-Related Intracerebral Hemorrhage (2018) Murphy MP, Kuramatsu J, Leasure A, Falcone GJ, Kamel H, Sansing LH, Kourkoulis C, et al. Journal article Identification of nine new susceptibility loci for endometrial cancer (2018) O'Mara TA, Glubb DM, Amant F, Annibali D, Ashton K, Attia J, Auer PL, et al. Journal article Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility (2018) Earp M, Tyrer JP, Winham SJ, Lin HY, Chornokur G, Dennis J, Aben KKH, et al. Journal article Spectroscopic and Computational Studies of Spin States of Iron(IV) Nitrido and Imido Complexes (2017) Bucinsky L, Breza M, Lee WT, Hickey AK, Dickie DA, Nieto I, Degayner JA, et al. Journal article III-V dielectric metasurfaces: enhanced nonlinearities and emission control (2017) Liu S, Vaskin A, Vabishchevich P, Addamane S, Keeler GA, Reno J, Yang Y, et al. Conference contribution Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci (2017) Kar SP, Adler E, Tyrer J, Hazelett D, Anton-Culver H, Bandera EV, Beckmann M, et al. Journal article Final analysis of time to subsequent disease progression/death in patients with metastatic enteropancreatic neuroendocrine tumours progressing under placebo and switched to lanreotide autogel/depot 120mg in the CLARINET open-label extension (2017) Cwikla JB, Wolin EM, Pavel ME, Phan AT, Raderer M, Sedlackova E, Cadiot G, et al. Conference contribution